US6700024010
US6700024010
Novavax, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.123.479.000 | 682.162.000 | 64.7% |
| Cost of Revenue | 73.040.000 | 202.739.000 | 64.0% |
| Gross Profit | 1.050.439.000 | 479.423.000 | 119.1% |
| 499.799.000 | 728.354.000 | 31.4% | |
| Operating Income | 550.640.000 | -248.931.000 | 321.2% |
| Pretax Income | 442.167.000 | -176.615.000 | 350.4% |
| Net Income Common Stockholders | 440.302.000 | -187.499.000 | 334.8% |
| -- | -- | -- | |
| -- | -- | -- |